N-Demethyl ondansetron
CAS: 99614-14-9
Rif. 3D-FD21008
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione |
Informazioni sul prodotto
- 1,2,3,9-Tetrahydro-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-oneDesmethylondansetron
- 1,2,3,9-Tetrahydro-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
- 3-[(2-Methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
- 3-[(2-Methylimidazol-1-yl)methyl]-1,2,3,9-tetrahydrocarbazol-4-one
- 4H-carbazol-4-one, 1,2,3,9-tetrahydro-3-[(2-methyl-1H-imidazol-1-yl)methyl]-
- Desmethylondansetron
- N-desmethylondansetron
- 1,2,3,9-Tetrahydro-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one
N-Demethyl ondansetron is a drug that has been used to treat nausea and vomiting. It is an immunogen with a high degree of cross-reactivity, which may lead to false positives in the assay. The antiserum was optimized for actinomycetes, including filamentous fungi. After the optimization step, the assay sensitivity was increased by 20%. This increase in sensitivity led to an improved yield rate of 15%, due to the use of less sample material.